These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12417449)

  • 41. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
    Azoulay D; Urshansky N; Karni A
    J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis.
    Głabiński A; Mirecka M; Pokoca L
    Acta Neurol Scand; 1995 Apr; 91(4):276-9. PubMed ID: 7542828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients.
    Selmaj K; Nowak Z; Tchórzewski H
    J Neurol Sci; 1988 May; 85(1):67-76. PubMed ID: 3260270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
    Etesam Z; Nemati M; Ebrahimizadeh MA; Ebrahimi HA; Hajghani H; Khalili T; Frootan R; Zinoddini N; Jafarzadeh A
    J Mol Neurosci; 2016 Sep; 60(1):94-101. PubMed ID: 27370539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remyelination modulators in multiple sclerosis patients.
    Al-Temaimi R; AbuBaker J; Al-Khairi I; Alroughani R
    Exp Mol Pathol; 2017 Dec; 103(3):237-241. PubMed ID: 29108879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
    Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
    Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory effects of cytokines and cyclosporine A on peripheral blood mononuclear cells from stable multiple sclerosis patients.
    Guillen C; Prieto A; Alvarez-Cermeño JC; de la Piedra M; Gimeno A; Alvarez-Mon M
    Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):527-49. PubMed ID: 10466078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids.
    Gallai V; Sarchielli P; Trequattrini A; Franceschini M; Floridi A; Firenze C; Alberti A; Di Benedetto D; Stragliotto E
    J Neuroimmunol; 1995 Feb; 56(2):143-53. PubMed ID: 7860710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
    Mehrpour M; Akhoundi FH; Delgosha M; Keyvani H; Motamed MR; Sheibani B; Meysamie A
    Neurologist; 2015 Oct; 20(4):57-60. PubMed ID: 26468869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levels of brain-derived neurotrophic factor in patients with multiple sclerosis.
    Naegelin Y; Saeuberli K; Schaedelin S; Dingsdale H; Magon S; Baranzini S; Amann M; Parmar K; Tsagkas C; Calabrese P; Penner IK; Kappos L; Barde YA
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2251-2261. PubMed ID: 33031634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of immunomodulatory drugs on in vitro production of brain-derived neurotrophic factor.
    Petereit HF; Lindemann H; Schoppe S
    Mult Scler; 2003 Feb; 9(1):16-20. PubMed ID: 12617262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
    Kochanowski J; Uchman D; Litwiniuk A; Kalisz M; Wolinska-Witort E; Martynska L; Baranowska B; Bik W
    Neuro Endocrinol Lett; 2015; 36(2):148-52. PubMed ID: 26071584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients.
    Canto E; Isobe N; Didonna A; ; Hauser SL; Oksenberg JR
    J Neuroinflammation; 2018 Mar; 15(1):72. PubMed ID: 29514694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
    Thöne J; Ellrichmann G; Seubert S; Peruga I; Lee DH; Conrad R; Hayardeny L; Comi G; Wiese S; Linker RA; Gold R
    Am J Pathol; 2012 Jan; 180(1):267-74. PubMed ID: 22152994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fitness Shifts the Balance of BDNF and IL-6 from Inflammation to Repair among People with Progressive Multiple Sclerosis.
    Devasahayam AJ; Kelly LP; Williams JB; Moore CS; Ploughman M
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis.
    Lamers KJ; de Reus HP; Jongen PJ
    Mult Scler; 1998 Jun; 4(3):124-6. PubMed ID: 9762659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
    Damiano S; Sasso A; De Felice B; Terrazzano G; Bresciamorra V; Carotenuto A; Orefice NS; Orefice G; Vacca G; Belfiore A; Santillo M; Mondola P
    Brain Res Bull; 2015 Sep; 118():1-6. PubMed ID: 26327496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Klotho gene expression decreases in peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting multiple sclerosis.
    Karami M; Mehrabi F; Allameh A; Pahlevan Kakhki M; Amiri M; Emami Aleagha MS
    J Neurol Sci; 2017 Oct; 381():305-307. PubMed ID: 28991703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.